MedTrace Logo

Improving Antiretroviral Medication Adherence Among HIV-infected Youth: Phase I

NCT01253850 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2017-04-17

No results posted yet for this study

Summary

HIV is increasing among adolescents and young adults in the US. Antiretroviral medications, when taken correctly (≥90% of prescribed doses taken), can vastly improve life expectancy. However, adherence among HIV-infected young people is suboptimal, and few interventions are available to help adolescents adhere to treatment.

The first phase of the study is an intervention development phase, which includes conducting interviews with 40 HIV-infected youth for input on the adaptation of the approach. The information obtained from the qualitative interviews is used to adapt the Life-Steps intervention (designed by our group for HIV-infected adults) to be responsive to the needs of HIV-infected adolescents, with acceptability of topics and content, and feasibility of intervention delivery to be tested in an open pilot trial.

Conditions

  • HIV Infection

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER

  • Boston Children's Hospital

    collaborator OTHER

  • Harvard Medical School (HMS and HSDM)

    collaborator OTHER

  • Fenway Community Health

    lead OTHER

Principal Investigators

  • Matthew J. Mimiaga, ScD MPH · Fenway Health and Massachusetts General Hospital

Eligibility

Min Age
13 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2011-07-31
Completion
2013-03-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01253850 on ClinicalTrials.gov